Lower Extremity Review
RELJA Innovations’ patent-pending MIS Precision Chevron Bunion System preserves the benefits of the proven chevron osteotomy for bunion correction, while allowing the procedure to be completed precisely and with a minimally invasive technique. It consists of a single pre-sterilized part number that…
The ReAbility WorkStation™ (RWS) can significantly help physical therapy clinics or health clubs add a new revenue source while improving the health and fitness outcomes of people with moderate to severe physical disabilities. The RWS functional design requires only 370 SF of floor space…
Hurdle, an innovative footwear brand, announced the launch of its tech-infused, athleisure sock line, MicroGravity Matrix. These socks, which are precision engineered and patented, offer a soft, multi-dimensional support network that offloads weight away from vulnerable areas of the…
Waco Shoe Company has announced the inaugural products of the men’s Revitalign® footwear line: the Brewster™, Dundee™, and Siesta™ casual styles. The company designs, develops, and sells Revitalign® lifestyle footwear for all-day comfort built around its innovative, research-based…
Z-Liner insoles adapt and form to the shape and pressure points of the wearer’s feet after only 1 week of wear, whether they are flat footed, high arched, or anything in between. They’re also machine washable and anti-bacterial, allowing the wearer to keep their feet clean and fresh.
A new biosensor capable of accurately monitoring the condition of a chronic wound, such as diabetic foot ulcers, has been developed by a team of engineers and clinical academics at Nottingham Trent University (NTU) and Nottingham University Hospitals (NUH) NHS Trust in the…
Hanger, Inc., a provider of orthotic and prosthetic (O&P) patient care services and solutions, announced the completion of its transaction to acquire Surestep, a manufacturer of custom pediatric orthotic devices. Financial details of the transaction were not disclosed.
Researchers in the National Nanotechnology and Research Center (UNAM) at Bilken University, have developed next-generation technology in the form of shoes with fiber sensors that have the potential to diagnose many health problems from gait disorders to Parkinson’s, and has implications for…
Using a miniature camera and a customized deep neural network, Cornell University researchers have developed a wristband that tracks the entire body posture in 3D. Called BodyTrak, it is the first wearable to track the full body pose with a single camera. If integrated into future smartwatches…
Amparo Prosthetics, an innovator in polymer prosthetic technologies, announced its partnership with Empire Medical, a centralized purchasing department for the independent U.S. orthotics and prosthetics (O&P) market. This new relationship will allow all the member practices of the…
Stanford University researchers have developed a boot-like exoskeleton that can assist with walking out in the “wild.” It uses machine-based learning to adapt to a wearer’s gait. The aim is to help people with mobility impairments, particularly older people, move throughout the world as they like.
The Amparo Confidence Socket enables a transformation in how prosthetic sockets are fabricated. By utilizing a never-before-used material, fabricating this lower limb socket is efficient and simple for an experienced prosthetist. Incorporating an innovative thermoplastic material allows for…
In its Global Status Report on Physical Activity 2022, the World Health Organization (WHO) offers its first assessment on the progress made in implementing the 20 policy recommendations outlined in its Global Action Plan on Physical Activity 2018-2030: More Active People…
By Cedric X. Bryant, PhD, FASCM
The purpose of this cadaveric study was to quantify the severity of medial knee injuries based on medial compartment gapping as measured by stress ultrasonography. Methods: In 8 cadaveric knees, the distance between the medial tibial and…
MOBILE and ENHANCE were similarly designed randomized trials of walking impaired adults with relapsing-remitting or progressive multiple sclerosis (MS) who received placebo or 10 mg prolonged-release (PR)-fampridine twice daily for 24 weeks. Both studies showed sustained and clinically…
Join
Stay in the loop with the latest news and updates! Subscribe now to receive exclusive content, special offers, and important announcements straight to your inbox. Don’t miss out – join our community today for all the latest updates delivered directly to you.